[go: up one dir, main page]

JP2008101014A - Method for producing 2-oxindole derivatives - Google Patents

Method for producing 2-oxindole derivatives Download PDF

Info

Publication number
JP2008101014A
JP2008101014A JP2007303418A JP2007303418A JP2008101014A JP 2008101014 A JP2008101014 A JP 2008101014A JP 2007303418 A JP2007303418 A JP 2007303418A JP 2007303418 A JP2007303418 A JP 2007303418A JP 2008101014 A JP2008101014 A JP 2008101014A
Authority
JP
Japan
Prior art keywords
group
atom
acid
alkyl
oxindole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007303418A
Other languages
Japanese (ja)
Other versions
JP4770826B2 (en
Inventor
Junichi Tsuboi
順一 坪井
Masahiko Hanko
正彦 半杭
Kenichi Namie
賢一 浪江
Yasuhiro Takahashi
康弘 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dai Nippon Printing Co Ltd
Original Assignee
Dai Nippon Printing Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dai Nippon Printing Co Ltd filed Critical Dai Nippon Printing Co Ltd
Priority to JP2007303418A priority Critical patent/JP4770826B2/en
Publication of JP2008101014A publication Critical patent/JP2008101014A/en
Application granted granted Critical
Publication of JP4770826B2 publication Critical patent/JP4770826B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

【課題】種々の医薬品や染料等の重要中間体である2−オキシインドール誘導体の製造に際し、特殊な原料等を使用せず、簡便な操作で高収率且つ高品質で該化合物を得ることが出来る新規な製造法の提供。
【解決手段】対応するイサチンのヒドラゾン体を、Wolff-Kischnar還元反応によって脱酸素して2−オキシインドール誘導体を得る反応を行なった後に、反応液をアルカリ性を保ったまま晶析させて取り出す、非常に純度の高い2−オキシインドール誘導体を得る製造方法。
【選択図】なし
[PROBLEMS] To obtain a high-yield and high-quality compound by a simple operation without using a special raw material in the production of 2-oxindole derivatives which are important intermediates of various pharmaceuticals and dyes. Provision of new manufacturing methods that can be performed.
[MEANS FOR SOLVING PROBLEMS] A corresponding hydrazone form of isatin is deoxygenated by a Wolff-Kischnar reduction reaction to obtain a 2-oxindole derivative, and then the reaction solution is crystallized while maintaining alkalinity. Process for obtaining a highly pure 2-oxindole derivative.
[Selection figure] None

Description

本発明は、2−オキシインドール誘導体の製造方法、特に該化合物の結晶取り出しの際にアルカリ性液から晶析させることにより高純度の該化合物を製造する方法に関する。   The present invention relates to a method for producing a 2-oxindole derivative, and more particularly to a method for producing a high-purity compound by crystallization from an alkaline solution during crystal extraction of the compound.

2−オキシインドール誘導体は、各種医薬品、農薬の、染料等の中間体として利用されている。   2-Oxindole derivatives are used as intermediates for various pharmaceuticals, agricultural chemicals and dyes.

例えば、充血性心臓病の強心剤として、2−オキシインドール骨格を有するアジベンダン(adibendan)   For example, adibendan having 2-oxindole skeleton as a cardiotonic agent for congestive heart disease

Figure 2008101014
の合成中間体として知られている。
Figure 2008101014
It is known as a synthetic intermediate.

また、種々の表皮成長の調節に有用なチロシンキナーゼ抑制剤も2−オキシインドール誘導体から製造されている。   Tyrosine kinase inhibitors useful for the regulation of various epidermal growth have also been produced from 2-oxindole derivatives.

2−オキシインドール誘導体は、次の反応式   The 2-oxindole derivative has the following reaction formula:

Figure 2008101014
(式中、Rはアルキル、アルコキシ、アリール、フェノキシ、ハロゲン、または水素を表す。)で示される方法により合成できることはすでに公知である(非特許文献1)。
Figure 2008101014
(Wherein, R represents alkyl, alkoxy, aryl, phenoxy, halogen, or hydrogen) is already known (Non-Patent Document 1).

当該方法によれば、イサチンが脱水メタノール中でヒドラジン水和物と反応して反応混合物の中で懸濁状のヒドラゾン体を形成する。この中間体は反応混合物から分離され、再結等で生成される。この中間体を、脱水エタノール中で強塩基、例えばナトリウムエトキシドの存在下、Wolff-Kischnar還元をする事により2−オキシインドール誘導体に変換される。   According to this method, isatin reacts with hydrazine hydrate in dehydrated methanol to form a suspended hydrazone in the reaction mixture. This intermediate is separated from the reaction mixture and produced by recrystallization or the like. This intermediate is converted to a 2-oxindole derivative by Wolff-Kischnar reduction in dehydrated ethanol in the presence of a strong base such as sodium ethoxide.

こうして得られた2−オキシインドール誘導体は、一般的に反応液を濃縮後に酸性水中で晶析させる事により粗結晶を得、更に各種溶媒中で再結処理を施して得られる。   The 2-oxindole derivative thus obtained is generally obtained by concentrating the reaction solution and then crystallizing it in acidic water to obtain a crude crystal, followed by recrystallization in various solvents.

例えば特許文献1では、反応液を濃縮後に酸性水で割り出した結晶をエーテルで洗浄後、EtOHで再結精製して2−オキシインドール誘導体を得ている。   For example, in Patent Document 1, a crystal obtained by concentrating a reaction solution and then indexed with acidic water is washed with ether and then recrystallized and purified with EtOH to obtain a 2-oxindole derivative.

特許文献2では、同じく反応液を濃縮後に酸性水中で晶析させ、得られた結晶をクロロホルム/エーテルで再結晶精製して目的物を得ている。
D.S.Soriano, J.Chem.Edu.70, 332(1993) 米国特許第4730004号明細書 米国特許第4160032号明細書
In Patent Document 2, similarly, the reaction solution is concentrated and crystallized in acidic water, and the obtained crystal is purified by recrystallization with chloroform / ether to obtain the desired product.
DSSoriano, J. Chem. Edu. 70, 332 (1993) U.S. Pat. No. 4730004 US Pat. No. 4,16,0032

上記の反応では、原料や中間体、生成物の2量化が起こり易いなどの理由で様々な副生物が生成する。極性、非極性の化合物が混在するために通常の方法では精製操作が極めて複雑となり、精製歩留りを低下させる原因となっている。上記の特許に記載された方法では、これら副生化合物を除去し、充分な純度の2−オキシインドール誘導体を得ることはできない。更に、酸化等により着色等も発生し、この着色が2−オキシインドール誘導体の結晶中に持ち込まれるため脱色操作も必要となり、取り出し操作が煩雑となるなど課題が多く、工業生産上の欠点となっている。   In the above reaction, various by-products are generated for the reason that dimerization of raw materials, intermediates, and products easily occurs. Since polar and nonpolar compounds coexist, the purification method becomes extremely complicated by the usual method, which causes a reduction in the purification yield. According to the method described in the above patent, these by-product compounds cannot be removed to obtain a 2-oxindole derivative having sufficient purity. Furthermore, coloring or the like is also generated due to oxidation or the like, and since this coloring is brought into the crystal of the 2-oxindole derivative, a decoloring operation is necessary, and there are many problems such as a complicated extraction operation, which is a disadvantage in industrial production. ing.

本発明者等は、これら先行技術の欠点を解決するべく鋭意研究を行なった結果、非常に単純な作業で高収率で非常に純度の高い最終生成物を得る方法を見出し、本発明に至った。   As a result of diligent research to solve these disadvantages of the prior art, the present inventors have found a method for obtaining a highly purified final product with a high yield by a very simple operation, and have led to the present invention. It was.

すなわち、本発明の方法は、
下記一般式(1)
That is, the method of the present invention comprises:
The following general formula (1)

Figure 2008101014
[式中R1は、水素原子、アルキル基、アルコキシ基、アルケニル基、アルキニル基、アリール基、アミノ基、アリールオキシ基、アミド基、ウレイド基、アリルオキシ基、ホルミル基、アシル基(ここで用いられるアシル基とは、カルボン酸のカルボキシル基から−OHを除いて誘導される基だけでなく、硫酸、硝酸、燐酸のような無機酸もしくはカルバミン酸、炭酸、スルホン酸、ホスホン酸のような有機酸から−OHを除いて誘導された基も含む、広義の酸から―OHを除いて誘導された基の意味である。)、ヒドロキシ基、カルバモイル基、アルキルあるいはアリールオキシカルボニル基、アルキルあるいはアリールオキシスルホニル基、アルキルあるいはアリールオキシチオカルボニル基、チオール基、アルキルあるいはアリールチオ基、アルキルあるいはアリールスルファモイル基、スルホンアミド基、アルキルあるいはアリールオキシスルホニルアミノ基、アルキルあるいはアリールオキシカルボニルアミノ基、カルボキシル基、アルキルあるいはアリールオキシカルボキシル基、C3―C6シクロアルキル基、アラルキル基、O原子又はS原子あるいはN原子を少なくとも1個含む5員もしくは6員複素芳香環、O原子又はS原子あるいはN原子を少なくとも1個含む5員もしくは6員複素飽和環を表す。
Figure 2008101014
[Wherein R1 represents a hydrogen atom, alkyl group, alkoxy group, alkenyl group, alkynyl group, aryl group, amino group, aryloxy group, amide group, ureido group, allyloxy group, formyl group, acyl group (used herein) An acyl group is not only a group derived by removing —OH from a carboxyl group of a carboxylic acid, but also an inorganic acid such as sulfuric acid, nitric acid, phosphoric acid, or an organic acid such as carbamic acid, carbonic acid, sulfonic acid, or phosphonic acid. Meaning a group derived by removing -OH from an acid in a broad sense, including a group derived by removing -OH from N), hydroxy group, carbamoyl group, alkyl or aryloxycarbonyl group, alkyl or aryloxy Sulfonyl group, alkyl or aryloxythiocarbonyl group, thiol group, alkyl or arylthiol O group, alkyl or arylsulfamoyl group, sulfonamido group, alkyl or aryloxysulfonylamino group, alkyl or aryloxycarbonylamino group, carboxyl group, alkyl or aryloxycarboxyl group, C3-C6 cycloalkyl group, aralkyl group Represents a 5-membered or 6-membered heteroaromatic ring containing at least one O atom, S atom or N atom, or a 5-membered or 6-membered heterosaturated ring containing at least one O atom, S atom or N atom.

式中R2、R3、R4、R5はそれぞれ同一または異なって、水素原子、ハロゲン、ニトロ基、シアノ基、アミノ基、トリフルオロメチル基、アルキル基、アルコキシ基、アルケニル基、アルキニル基、アリール基、アミノ基、アリールオキシ基、アミド基、ウレイド基、アリールオキシ基、ホルミル基、アシル基(ここで用いられるアシル基とは、カルボン酸のカルボキシル基から−OHを除いて誘導される基だけでなく、硫酸、硝酸、燐酸のような無機酸もしくはカルバミン酸、炭酸、スルホン酸、ホスホン酸のような有機酸から−OHを除いて誘導された基も含む、広義の酸から―OHを除いて誘導された基の意味である。)、ヒドロキシ基、カルバモイル基、アルキルあるいはアリールオキシカルボニル基、アルキルあるいはアリールオキシスルホニル基、アルキルあるいはアリールオキシチオカルボニル基、チオール基、アルキルあるいはアリールチオ基、アルキルあるいはアリールスルファモイル基、スルホンアミド基、アルキルあるいはアリールオキシスルホニルアミノ基、アルキルあるいはアリールオキシカルボニルアミノ基、カルボキシル基、アルキルあるいはアリールオキシカルボキシル基、C3―C6シクロアルキル基、アラルキル基、O原子又はS原子あるいはN原子を少なくとも1個含む5員もしくは6員複素芳香環、O原子又はS原子あるいはN原子を少なくとも1個含む5員もしくは6員複素飽和環を表す。   In the formula, R2, R3, R4 and R5 are the same or different and each represents a hydrogen atom, halogen, nitro group, cyano group, amino group, trifluoromethyl group, alkyl group, alkoxy group, alkenyl group, alkynyl group, aryl group, Amino group, aryloxy group, amide group, ureido group, aryloxy group, formyl group, acyl group (acyl group used here is not only a group derived by removing -OH from a carboxyl group of a carboxylic acid. Derived by removing -OH from broad acids, including groups derived from inorganic acids such as sulfuric acid, nitric acid, phosphoric acid or organic acids such as carbamic acid, carbonic acid, sulfonic acid, phosphonic acid, by removing -OH Meaning hydroxy group, carbamoyl group, alkyl or aryloxycarbonyl group, alkyl or aryl. Oxysulfonyl group, alkyl or aryloxythiocarbonyl group, thiol group, alkyl or arylthio group, alkyl or arylsulfamoyl group, sulfonamido group, alkyl or aryloxysulfonylamino group, alkyl or aryloxycarbonylamino group, carboxyl group An alkyl or aryloxycarboxyl group, a C3-C6 cycloalkyl group, an aralkyl group, a 5- or 6-membered heteroaromatic ring containing at least one O atom or S atom or N atom, an O atom or S atom or N atom at least It represents a 5-membered or 6-membered heterosaturated ring containing one.

また、R2とR3もしくはR3とR4もしくはR4とR5は互いに結合して環を形成してもよい。]で表されるイサチン誘導体を還元することによる得られる下記一般式(2)   R2 and R3 or R3 and R4 or R4 and R5 may be bonded to each other to form a ring. The following general formula (2) obtained by reducing the isatin derivative represented by

Figure 2008101014
[式中、R1、R2、R3、R4、R5は前記と同義である。]で表される2−オキシインドール誘導体の反応液をアルカリ性液から晶析させて取り出すことを特徴とする2−オキシインドール誘導体の製造方法を提供するものである。
Figure 2008101014
[Wherein R 1, R 2, R 3, R 4, R 5 have the same meanings as described above. The reaction solution of 2-oxindole derivative represented by the following formula is crystallized from an alkaline solution and taken out.

本発明法によれば、一般的な方法では製造が困難である高純度の2−オキシインドール誘導体を、単純な操作で収率良くしかも高純度で製造することができる。医薬品等の重要な原料となる2−オキシインドール誘導体の工業的な製造法として有用であり、その製造コストの大幅な低減を図ることが出来る。   According to the method of the present invention, a high-purity 2-oxindole derivative, which is difficult to produce by a general method, can be produced with high yield and high purity by a simple operation. It is useful as an industrial production method of 2-oxindole derivatives that are important raw materials for pharmaceuticals and the like, and can greatly reduce the production cost.

本発明の製造方法を詳細に説明する。
本発明では、まず公知の方法によりイサチン誘導体の還元により2−オキシインドール誘導体への変換を行なう。本発明の製造法で用いる原料であるイサチン誘導体は一般式(1)で表される化合物である(式中、R1、R2、R3、R4、R5は前記と同義である。)。
The production method of the present invention will be described in detail.
In the present invention, the isatin derivative is first converted into a 2-oxindole derivative by a known method. The isatin derivative which is a raw material used in the production method of the present invention is a compound represented by the general formula (1) (wherein R1, R2, R3, R4 and R5 have the same meanings as described above).

原料イサチン誘導体の製造方法は特に限定されないが、例えば、置換アニリンからイソニトロソアセトアニリド誘導体とした後に閉環反応により得られたイサチン誘導体を使用することができる。   Although the manufacturing method of a raw material isatin derivative is not specifically limited, For example, the isatin derivative obtained by making an isonitrosoacetanilide derivative from substituted aniline and then ring-closing reaction can be used.

一般的には、イサチン誘導体を適正な溶媒中でヒドラジン水和物と反応させてヒドラゾン誘導体を形成する。この中間体はそのまま次工程へ使用されるか若しくは反応混合物から分離された後に、適正な溶媒中で強塩基、例えばナトリウムエトキシドの存在下、Wolff-Kischnar還元を施して2−オキシインドール誘導体に変換する。   In general, an isatin derivative is reacted with hydrazine hydrate in a suitable solvent to form a hydrazone derivative. This intermediate is used as is in the next step or separated from the reaction mixture and then subjected to Wolff-Kischnar reduction in the presence of a strong base, such as sodium ethoxide, in an appropriate solvent to give the 2-oxindole derivative. Convert.

こうして得られた一般式(2)で表される2−オキシインドール誘導体は結晶として取り出されるが、本発明の重要な点は、晶析時の系内のpHをアルカリ性に保つ点である。強アルカリを使用して反応を行なっているため、反応終了時点ではpH>13の強アルカリ性となっており、一般的には、反応液濃縮、酸性水での晶析、濾過により結晶を取り出しているが、この操作では、反応中に副生する様々な不純物を持ち込んでしまい、取り出した結晶を再度再結等により精製を行なわなければならない。   The 2-oxindole derivative represented by the general formula (2) thus obtained is taken out as a crystal. The important point of the present invention is that the pH in the system during crystallization is kept alkaline. Since the reaction is carried out using a strong alkali, it is strongly alkaline with a pH> 13 at the end of the reaction. Generally, the crystals are taken out by concentration of the reaction solution, crystallization with acidic water, and filtration. However, in this operation, various impurities by-produced during the reaction are brought in, and the extracted crystal must be purified again by recrystallization or the like.

ところが、副生する不純物は目的の2−オキシインドール誘導体と類似の性質を持っているため、精製効果が見られず、結果として多大な費用、労力を浪費することになる。   However, the impurities produced as a by-product have properties similar to those of the target 2-oxindole derivative, so that a purification effect is not seen, resulting in wasting a lot of cost and labor.

一方、反応液そのままでも晶析は可能であるが、2−オキシインドール誘導体はアルカリ金属と塩を形成するために、水系の晶析系では濾液へのロスが大きくなり収率の低下につながってしまう。塩として取り出す系で晶析させた場合は、その塩を再度中和により結晶を得なければならず、操作として煩雑になる上、精製効果が得られない。   On the other hand, crystallization is possible even with the reaction solution as it is, but since the 2-oxindole derivative forms a salt with an alkali metal, in an aqueous crystallization system, the loss to the filtrate increases, leading to a decrease in yield. End up. In the case of crystallization in a system for taking out as a salt, the salt must be neutralized again to obtain crystals, which is complicated in operation and the purification effect cannot be obtained.

本発明では、晶析の際に酸を添加してpHを13〜7.5の間に調整して晶析させる。これにより、収率を落とさず、しかも各種不純物をほとんど持ち込まずに目的物の結晶を得ることが出来る。   In the present invention, acid is added during crystallization to adjust the pH between 13 and 7.5 for crystallization. Thereby, the target crystal can be obtained without reducing the yield and introducing almost no impurities.

ここで使用される酸は、塩酸、硫酸、硝酸などの鉱酸や酢酸、p−トルエンスルホン酸、などの有機酸から選択されるが、特に工業的見地から塩酸が有利である。   The acid used here is selected from mineral acids such as hydrochloric acid, sulfuric acid and nitric acid, and organic acids such as acetic acid and p-toluenesulfonic acid, and hydrochloric acid is particularly advantageous from an industrial point of view.

使用される酸の使用量は、還元反応でのアルカリ使用量により一定しないが、通常、使用したアルカリに対して1当量以下、好ましくは0.85〜0.95当量の範囲である。   The amount of acid used is not constant depending on the amount of alkali used in the reduction reaction, but is usually 1 equivalent or less, preferably 0.85 to 0.95 equivalent to the alkali used.

このように本発明で得られた2−オキシインドール誘導体は、HPLCでの測定で99.5%以上の純度で得ることができ、通常の使用であれば、取り出し後に再結晶、カラムクロマト、蒸留等の精製を施す必要はない。   As described above, the 2-oxindole derivative obtained in the present invention can be obtained with a purity of 99.5% or more as measured by HPLC. If it is used normally, recrystallization, column chromatography, distillation after removal. It is not necessary to perform such purification.

以下に、実施例を掲げて本発明を具体的に説明するが、本発明はこれらの実施例に限定されるものではない。
(実施例1)
攪拌機、還流冷却器、温度計の備わった500mlフラスコに、5−フルオロイサチン100g(0.61mol)とメタノール300mlを仕込み、室温攪拌下、60%ヒドラジン水溶液56.8g(0.11mol)を徐々に添加した。添加終了後加温を行ない13時間以上加熱還流した。反応終了後、冷却し、析出した結晶を濾過した。メタノール80mlで洗浄後、乾燥し、3−ヒドラジノ−5−フルオロ−2−オキシインドール103.7gを得た。収率95.0%。黄色結晶。
EXAMPLES The present invention will be specifically described below with reference to examples, but the present invention is not limited to these examples.
(Example 1)
A 500 ml flask equipped with a stirrer, reflux condenser and thermometer was charged with 100 g (0.61 mol) of 5-fluoroisatin and 300 ml of methanol, and gradually 56.8 g (0.11 mol) of 60% hydrazine aqueous solution was stirred at room temperature. Added to. After completion of the addition, the mixture was heated and refluxed for 13 hours or longer. After completion of the reaction, the mixture was cooled and the precipitated crystals were filtered. After washing with 80 ml of methanol and drying, 103.7 g of 3-hydrazino-5-fluoro-2-oxindole was obtained. Yield 95.0%. Yellow crystals.

(実施例2)
攪拌機、還流冷却器、温度計の備わった500mlフラスコに3−ヒドラジノ−5−フルオロ−2−オキシインドール100.0g(0.56mol)とメタノール400mlを仕込み、煮沸還流させた。この懸濁液に水酸化ナトリウム44.8g(1.12mol)をメタノール225mlに溶解した溶液を徐々に滴下した。滴下終了後、約3時間煮沸反応を継続し反応を完結させた。反応終了後、MeOH330mlを常圧で回収した。回収後、水250mlを加えて溶解し、これに4N塩酸水250mlを徐々に加えて晶析させた。一夜氷冷下攪拌した後、結晶を濾過した。濾液のpHは12.3であった。濾過した結晶を水で洗液がpH7となるまで洗浄した後に乾燥し、5−フルオロ−2−オキシインドール74.3gを得た。収率85.0%。微黄白色針状結晶。得られた結晶をHPLCで分析した結果、目的化合物の面積百分率は99.8%であった。
(Example 2)
A 500 ml flask equipped with a stirrer, a reflux condenser, and a thermometer was charged with 100.0 g (0.56 mol) of 3-hydrazino-5-fluoro-2-oxindole and 400 ml of methanol and boiled and refluxed. A solution prepared by dissolving 44.8 g (1.12 mol) of sodium hydroxide in 225 ml of methanol was gradually added dropwise to this suspension. After completion of the dropwise addition, the boiling reaction was continued for about 3 hours to complete the reaction. After completion of the reaction, 330 ml of MeOH was recovered at normal pressure. After recovery, 250 ml of water was added and dissolved, and 250 ml of 4N hydrochloric acid was gradually added to cause crystallization. After stirring overnight under ice cooling, the crystals were filtered. The pH of the filtrate was 12.3. The filtered crystals were washed with water until the washing solution had a pH of 7, and then dried to obtain 74.3 g of 5-fluoro-2-oxindole. Yield 85.0%. Slight yellowish white acicular crystals. As a result of analyzing the obtained crystals by HPLC, the area percentage of the target compound was 99.8%.

(実施例3)
実施例2の3−ヒドラジノ−5−フルオロイサチンを3−ヒドラジノ−5−クロロイサチンに変えた以外は同様の反応、後処理により5−クロロ−2−オキシインドールを得た。収率87.2%。微褐白色針状結晶。濾液のpHは12.2であった。
(Example 3)
5-Chloro-2-oxindole was obtained by the same reaction and post-treatment except that 3-hydrazino-5-fluoroisatin of Example 2 was changed to 3-hydrazino-5-chloroisatin. Yield 87.2%. Fine brownish white acicular crystals. The pH of the filtrate was 12.2.

得られた結晶をHPLCで分析した結果、目的化合物の面積百分率は99.8%であった。   As a result of analyzing the obtained crystals by HPLC, the area percentage of the target compound was 99.8%.

(比較例1)
攪拌機、還流冷却器、温度計の備わった500mlフラスコに3−ヒドラジノ−5−フルオロ−2−オキシインドール100.0g(0.56mol)とメタノール400mlを仕込み、煮沸還流させた。この懸濁液に水酸化ナトリウム44.8g(1.12mol)をメタノール225mlに溶解した溶液を徐々に滴下した。滴下終了後、約3時間煮沸反応を継続し反応を完結させた。反応終了後、MeOH330mlを常圧で回収する。回収終了後、水250mlを添加し、更に4N塩酸水295mlを徐々に加えて晶析させた。一夜氷冷下攪拌し、結晶を濾過した。濾液のpHは1.8であった。濾過した結晶を水で洗液がpH7となるまで洗浄した後に乾燥し、5−フルオロ−2−オキシインドール76.3gを得た。収率87.3%。微褐白色針状結晶。
(Comparative Example 1)
A 500 ml flask equipped with a stirrer, a reflux condenser and a thermometer was charged with 100.0 g (0.56 mol) of 3-hydrazino-5-fluoro-2-oxindole and 400 ml of methanol and boiled to reflux. A solution prepared by dissolving 44.8 g (1.12 mol) of sodium hydroxide in 225 ml of methanol was gradually added dropwise to this suspension. After completion of the dropwise addition, the boiling reaction was continued for about 3 hours to complete the reaction. After completion of the reaction, 330 ml of MeOH is recovered at normal pressure. After the completion of recovery, 250 ml of water was added, and 295 ml of 4N hydrochloric acid was gradually added to cause crystallization. The mixture was stirred overnight under ice-cooling, and the crystals were filtered. The pH of the filtrate was 1.8. The filtered crystals were washed with water until the washing solution had a pH of 7, and then dried to obtain 76.3 g of 5-fluoro-2-oxindole. Yield 87.3%. Fine brownish white acicular crystals.

得られた結晶をHPLCで分析した結果、目的化合物の面積百分率は98.7%であった。   As a result of analyzing the obtained crystals by HPLC, the area percentage of the target compound was 98.7%.

Claims (4)

下記一般式(1)
Figure 2008101014
[式中R1は、水素原子、アルキル基、アルコキシ基、アルケニル基、アルキニル基、アリール基、アミノ基、アリールオキシ基、アミド基、ウレイド基、アリルオキシ基、アシル基(ここで用いられるアシル基とは、カルボン酸のカルボキシル基から−OHを除いて誘導される基だけでなく、硫酸、硝酸、燐酸のような無機酸もしくはカルバミン酸、炭酸、スルホン酸、ホスホン酸のような有機酸から−OHを除いて誘導された基も含む、広義の酸から−OHを除いて誘導された基の意味である。)、カルバモイル基、チオール基、アルキルあるいはアリールチオ基、アルキルあるいはアリールスルファモイル基、スルホンアミド基、アルキルあるいはアリールオキシスルホニルアミノ基、アルキルあるいはアリールオキシカルボニルアミノ基、C3―C6シクロアルキル基、アラルキル基、O原子又はS原子あるいはN原子を少なくとも1個含む5員もしくは6員複素芳香環、O原子又はS原子あるいはN原子を少なくとも1個含む5員もしくは6員複素飽和環を表す。
式中R2、R3、R4、R5はそれぞれ同一または異なって、水素原子、アルキル基、アルコキシ基、ハロゲン、アリール基、トリフルオロメチル基、又はC3―C6シクロアルキル基を表す。また、R2とR3もしくはR3とR4もしくはR4とR5は互いに結合して環を形成してもよい。]で表されるイサチン誘導体を還元することにより得られる下記一般式(2)
Figure 2008101014
[式中、R1、R2、R3、R4、R5は前記と同義である。]で表される2−オキシインドール誘導体の反応液のpHを7.5〜13に調整し、生成した2−オキシインドール誘導体を晶析させて取り出すことを特徴とする2−オキシインドール誘導体の製造方法。
The following general formula (1)
Figure 2008101014
[Wherein R1 represents a hydrogen atom, an alkyl group, an alkoxy group, an alkenyl group, an alkynyl group, an aryl group, an amino group, an aryloxy group, an amide group, a ureido group, an allyloxy group, an acyl group (the acyl group used herein) Is not only a group derived by removing -OH from the carboxyl group of the carboxylic acid, but also -OH from inorganic acids such as sulfuric acid, nitric acid, phosphoric acid or organic acids such as carbamic acid, carbonic acid, sulfonic acid, phosphonic acid. Meaning a group derived by removing -OH from an acid in a broad sense, including a group derived by removing), carbamoyl group, thiol group, alkyl or arylthio group, alkyl or arylsulfamoyl group, sulfone Amido group, alkyl or aryloxysulfonylamino group, alkyl or aryloxycarbonylamino Group, C3-C6 cycloalkyl group, aralkyl group, 5-membered or 6-membered heteroaromatic ring containing at least one O atom or S atom or N atom, 5-membered containing at least one O atom, S atom or N atom or Represents a 6-membered hetero saturated ring.
In the formula, R2, R3, R4 and R5 are the same or different and each represents a hydrogen atom, an alkyl group, an alkoxy group, a halogen, an aryl group, a trifluoromethyl group, or a C3-C6 cycloalkyl group. R2 and R3, R3 and R4, or R4 and R5 may be bonded to each other to form a ring. The following general formula (2) obtained by reducing the isatin derivative represented by
Figure 2008101014
[Wherein R 1, R 2, R 3, R 4, R 5 have the same meanings as described above. The pH of the reaction solution of the 2-oxindole derivative represented by the formula is adjusted to 7.5 to 13, and the produced 2-oxindole derivative is crystallized and taken out. Method.
R1が水素原子、R2、R3、R4、R5のいずれかがハロゲン原子である請求項1記載の2−オキシインドール誘導体の製造方法。   The method for producing a 2-oxindole derivative according to claim 1, wherein R1 is a hydrogen atom, and any of R2, R3, R4, and R5 is a halogen atom. R1、R2、R4、R5が水素原子、R3がフッ素またはクロル原子である請求項1乃至2記載の2−オキシインドール誘導体の製造方法。   The method for producing a 2-oxindole derivative according to claim 1 or 2, wherein R1, R2, R4, and R5 are hydrogen atoms, and R3 is a fluorine or chloro atom. 2−オキシインドール誘導体の反応液のpHを7.5〜13に調整する際の酸の使用量が、イサチン誘導体の還元反応において使用するアルカリに対して0.85〜0.95当量の範囲である請求項1乃至3記載の2−オキシインドール誘導体の製造方法。   When the pH of the reaction solution of 2-oxindole derivative is adjusted to 7.5 to 13, the amount of acid used is in the range of 0.85 to 0.95 equivalent to the alkali used in the reduction reaction of the isatin derivative. A method for producing a 2-oxindole derivative according to any one of claims 1 to 3.
JP2007303418A 2007-11-22 2007-11-22 Method for producing 2-oxindole derivatives Expired - Fee Related JP4770826B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007303418A JP4770826B2 (en) 2007-11-22 2007-11-22 Method for producing 2-oxindole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007303418A JP4770826B2 (en) 2007-11-22 2007-11-22 Method for producing 2-oxindole derivatives

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004108210A Division JP4078328B2 (en) 2004-03-31 2004-03-31 Method for producing 2-oxindole derivatives

Publications (2)

Publication Number Publication Date
JP2008101014A true JP2008101014A (en) 2008-05-01
JP4770826B2 JP4770826B2 (en) 2011-09-14

Family

ID=39435608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007303418A Expired - Fee Related JP4770826B2 (en) 2007-11-22 2007-11-22 Method for producing 2-oxindole derivatives

Country Status (1)

Country Link
JP (1) JP4770826B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246326A1 (en) 2009-05-02 2010-11-03 Bayer CropScience AG Method for producing oxindoles and ortho-substituted anilines and their use as intermediate products for syntheses
WO2012028162A1 (en) 2010-09-01 2012-03-08 Bayer Cropscience Ag Process for preparing oxindoles and ortho-substituted anilines and the use thereof as intermediates for syntheses
WO2014041052A1 (en) 2012-09-17 2014-03-20 Bayer Cropscience Ag Continuous method for producing ortho-substituted anilines in a flow reactor
US8986938B2 (en) 2009-06-22 2015-03-24 Sumitomo Heavy Industries, Ltd. Microbial activity improvement agent, microbial activity improvement method, and biological waste treatment method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160032A (en) * 1973-11-21 1979-07-03 Sandoz, Inc. Oxindoles as sleep-inducers
JPS6226269A (en) * 1985-07-09 1987-02-04 フアイザ−・インコ−ポレ−テツド Novel 1-substituted oxindole-3-carboxamides, their preparation and anti-inflammatory analgesic compositions
JPH07196610A (en) * 1993-12-28 1995-08-01 Kuraray Co Ltd Method for producing 5-chloro-2-oxindole
JP2000239253A (en) * 1999-01-16 2000-09-05 Xingnong Co Ltd Production of 2-oxyindole
US20040014986A1 (en) * 1999-12-27 2004-01-22 Wolfram Hendel Method for producing oxindoles

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160032A (en) * 1973-11-21 1979-07-03 Sandoz, Inc. Oxindoles as sleep-inducers
JPS6226269A (en) * 1985-07-09 1987-02-04 フアイザ−・インコ−ポレ−テツド Novel 1-substituted oxindole-3-carboxamides, their preparation and anti-inflammatory analgesic compositions
JPH07196610A (en) * 1993-12-28 1995-08-01 Kuraray Co Ltd Method for producing 5-chloro-2-oxindole
JP2000239253A (en) * 1999-01-16 2000-09-05 Xingnong Co Ltd Production of 2-oxyindole
US20040014986A1 (en) * 1999-12-27 2004-01-22 Wolfram Hendel Method for producing oxindoles

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246326A1 (en) 2009-05-02 2010-11-03 Bayer CropScience AG Method for producing oxindoles and ortho-substituted anilines and their use as intermediate products for syntheses
CN102459163A (en) * 2009-05-02 2012-05-16 拜尔农作物科学股份公司 Process for the preparation of oxindoles and ortho-substituted anilines and their use as synthesis intermediates
US8492590B2 (en) 2009-05-02 2013-07-23 Bayer Cropscience Ag Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses
CN102459163B (en) * 2009-05-02 2015-05-13 拜尔农作物科学股份公司 Process for the preparation of oxindoles and ortho-substituted anilines and their use as synthetic intermediates
US9242934B2 (en) 2009-05-02 2016-01-26 Bayer Cropscience Ag Process for the preparation of oxindoles and ortho-substituted anilines and their use as intermediates for syntheses
US8986938B2 (en) 2009-06-22 2015-03-24 Sumitomo Heavy Industries, Ltd. Microbial activity improvement agent, microbial activity improvement method, and biological waste treatment method
JP5736308B2 (en) * 2009-06-22 2015-06-17 住友重機械工業株式会社 Microbial activity improving agent, microbial activity improving method, and biological waste treatment method
WO2012028162A1 (en) 2010-09-01 2012-03-08 Bayer Cropscience Ag Process for preparing oxindoles and ortho-substituted anilines and the use thereof as intermediates for syntheses
WO2014041052A1 (en) 2012-09-17 2014-03-20 Bayer Cropscience Ag Continuous method for producing ortho-substituted anilines in a flow reactor

Also Published As

Publication number Publication date
JP4770826B2 (en) 2011-09-14

Similar Documents

Publication Publication Date Title
JP4386723B2 (en) New method
EP3653607B1 (en) Process for the preparation of enantiomerically enriched 3-aminopiperidine
JP4770826B2 (en) Method for producing 2-oxindole derivatives
JP6592085B2 (en) Preparation method of revaprazan hydrochloride
WO2003076374A1 (en) PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
JP7379470B2 (en) Method of preparation of lenvatinib
US9828340B2 (en) Asymmetric synthesis of a substituted pyrrolidine-2-carboxamide
JP4078328B2 (en) Method for producing 2-oxindole derivatives
EP2118058B9 (en) Method for the preparation of 5-benzyloxy-2-(4-benzyloxphenyl)-3-methyl-1h-indole
KR20010076278A (en) 3-(1-Hydroxy-Pentylidene)-5-Nitro-3H-Benzofuran-2-One, a Process for the Preparation thereof and the Use thereof
JP5640283B2 (en) Process for the preparation of pyrimidine derivatives
TWI478914B (en) Method for preparing 5-(2-amino-pyrimidin-4-yl)-2-aryl-1H-pyrrole-3-carboxamide
KR101894091B1 (en) New method for preparation of chromanone derivatives
KR102719583B1 (en) A novel manufacturing process for teriflunomide
CN105037160A (en) A kind of method for preparing vitamin B1 intermediate
JP5963222B2 (en) Method for producing DFMB derivative
JP2010189293A (en) Method for producing 1,4-dihydropyridine derivative
KR101152607B1 (en) Process for preparing 6-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-3-pyridin-4-yl-pyrazolo[1,5-a]pyrimidine
JP4968602B2 (en) Method for producing benzamide derivative
CN111978257A (en) Synthesis method of aldehyde group and carboxyl group-containing 1-methyl arene-1H-imidazole series compounds
KR20110007741A (en) Process for preparing 5- (substituted phenylalkyl) -2-alkoxy-5-amino-benzoic acid compound
KR20060087891A (en) Process for preparing azapyrone or salts thereof using 8- (2-pyrimidinyl) -8-aza-5-azoniaspiro [4.5] decanesulfonate salt and intermediates used in the method
CN111072560A (en) Preparation method of high-purity 4-hydroxy-quinoline-2 (1H) -ketone
EP1337519A1 (en) Process for the preparation of 1,5-disubstituated-3-amino-1,2,4-triazoles and substituted aminoguanidines as intermediate compounds
JP2004131395A (en) Method for producing aminouracil

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110301

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110502

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110524

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110606

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140701

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees